Pharma Pulse: A Regulatory Standoff for mRNA Flu Shots and the Dual Power of GLP-1s

In today’s Pharma Pulse, the FDA issues a rare “Refusal-to-File" for Moderna’s influenza vaccine, while new research confirms GLP-1s act as potent tools against chronic inflammation.